PUBLISHER: The Business Research Company | PRODUCT CODE: 1948632
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948632
Vital signs monitoring devices are essential medical instruments used to continuously or periodically measure and track key physiological parameters that indicate the body's critical functions. These devices are integral to modern healthcare as they help monitor physiological patterns and assist healthcare professionals in making timely and informed clinical decisions.
The primary categories of vital signs monitoring devices include blood pressure monitors, pulse oximeters, temperature monitoring devices, and glucose monitors. Pulse oximeters are compact devices that assess the oxygen saturation level in a person's blood, typically by attaching to a finger or earlobe. These devices are available in both standalone and portable forms and are utilized across various settings such as hospitals, clinics, home care, ambulatory centers, emergency departments, and more.
Tariffs are impacting the vital signs monitoring devices market by increasing costs of imported electronic components, sensors, and semiconductor-based parts used in monitoring systems. Portable and advanced monitoring device segments are most affected, particularly in Asia-Pacific regions such as China and Southeast Asia that serve as key manufacturing hubs. These cost pressures have led to higher device prices and supply chain adjustments. However, tariffs have also encouraged local manufacturing, component sourcing diversification, and investments in domestic production capabilities, supporting long-term market stability.
The vital signs monitoring devices market research report is one of a series of new reports from The Business Research Company that provides vital signs monitoring devices market statistics, including vital signs monitoring devices industry global market size, regional shares, competitors with a vital signs monitoring devices market share, detailed vital signs monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the vital signs monitoring devices industry. This vital signs monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vital signs monitoring devices market size has grown rapidly in recent years. It will grow from $11.07 billion in 2025 to $12.32 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increasing hospitalization rates, rising prevalence of chronic diseases, growing use of basic patient monitoring equipment, expansion of healthcare infrastructure, demand for routine vital sign assessment.
The vital signs monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $18.68 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to growth in home healthcare services, technological advancements in sensor technologies, rising geriatric population, increasing adoption of remote patient monitoring, demand for real-time clinical decision support. Major trends in the forecast period include growing adoption of continuous and remote vital signs monitoring, rising demand for portable and home healthcare monitoring devices, increased focus on early detection and preventive care, expansion of multi-parameter monitoring solutions, improved accuracy and reliability of non-invasive monitoring devices.
The rising incidence of cardiovascular diseases is expected to drive the expansion of the vital signs monitoring devices market in the coming years. Cardiovascular diseases encompass a range of disorders that impact the heart and blood vessels, frequently resulting in heart attacks, strokes, and other circulatory system issues. The prevalence of cardiovascular diseases is increasing due to higher rates of obesity, which raise the risk of hypertension, diabetes, and elevated cholesterol levels-factors that significantly contribute to heart-related problems. Vital signs monitoring devices play a crucial role in managing, diagnosing, and preventing cardiovascular diseases (CVDs). These devices aid in identifying early warning signs, tracking disease progression, and informing treatment strategies. For example, in October 2024, the US Centers for Disease Control and Prevention (CDC), a US government public health agency, reported that 919,032 individuals in the US died from cardiovascular disease in 2023, accounting for roughly one in every three deaths nationwide. Consequently, the growing prevalence of cardiovascular diseases is expected to propel the demand for vital signs monitoring devices.
Companies in the vital signs monitoring devices market are increasingly developing advanced technologies, such as early warning scoring tools integrated with monitoring devices, to minimize human error. These systems continuously monitor patient vital signs to detect early signs of clinical deterioration and prompt timely medical intervention. For instance, in July 2024, Huntleigh, a US-based medical equipment manufacturer, introduced the SC500 Series vital signs monitor. This high-performance device supports both spot checks and extended observations, bridging the gap between basic and multi-parameter monitors. It includes integrated early warning scoring tools and three-level alarms, making it ideal for long-term COVID-19 monitoring. The monitor features an 8-inch color display and can operate on battery or mains power. It provides comprehensive monitoring for adults, children, and newborns, including non-invasive blood pressure, pulse rate, pulse oximetry, 3-lead ECG, and an optional wireless tympanic temperature sensor. Additionally, the SC500 enhances workflow efficiency through standard connectivity options and compatibility with Smartsigns Central View monitoring software for centralized data management.
In September 2024, Becton, Dickinson and Company (BD), a US-based medical technology firm, acquired the Critical Care product group of Edwards Lifesciences Corporation for USD 4.2 billion. This acquisition allows Becton, Dickinson and Company to access advanced hemodynamic monitoring technologies, artificial intelligence (AI)-enabled clinical decision-support tools, and a portfolio of minimally invasive and noninvasive monitoring systems. As a result, the company enhances its smart connected care capabilities and strengthens its reach and integration across infusion and monitoring platforms. Edwards Lifesciences Corporation, based in the US, specializes in manufacturing advanced patient monitoring devices and sensors and is recognized for its leadership in hemodynamic monitoring technologies used in intensive care and surgical settings.
Major companies operating in the vital signs monitoring devices market are Medtronic Plc, Koninklijke Philips NV, GE Healthcare Technologies Inc, Omron Healthcare, Mindray Ltd, Masimo Corp, Nihon Kohden Corp, Lepu Medical Technology Co Ltd, Contec Medical Systems Co Ltd, A And D Company Ltd, Spacelabs Healthcare Inc, Schiller AG, Edan Instruments Inc, Shenzhen Comen Medical Instruments Co Ltd, Nonin Medical Inc, Recorders And Medicare Systems P Ltd, BPL Medical Technologies, SunTech Medical Inc, Rossmax International Ltd, Allengers Medical Systems Ltd, Huntleigh Healthcare LLC, BioBeat Technologies, Ababil Healthcare
North America was the largest region in the vital signs monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vital signs monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the vital signs monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The vital signs monitoring devices market consists of sales of respiratory rate monitors, wearable health trackers, multi-parameter patient monitors, and neonatal vital signs monitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vital Signs Monitoring Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses vital signs monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for vital signs monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vital signs monitoring devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.